Table 3 Clinical characteristics with respect to the HBV DNA levels of HBsAg-positive pregnant women

Subjects (n)

55

46

92

Gestational age (weeks)

36.65 ± 2.15

36.00 ± 3.00

35.66 ± 2.69^a

Peak TBA level (µmol/L)

41.5(28.05–61.85)

53.4(30.63–115.03)

67.3(44–108.8)^a

ALT (U/L)

16(10.5–21.5)

59.5(19–402.98)^a

198(56–517)^a

AST (U/L)

20(16–27.5)

50.5(23.5–365)^a

181(41–430)^a

TBIL (µmol/L)

6.8(4.65–8.85)

10.05(6.1–17.6)^a

10.4(7.15–45.45)^a

Preterm birth (n%)

15(27.3%)

22(47.8%)^a

53(57.6%)^a

MSAF (n%)

9(16.4%)

13(28.3%)

27(29.3%)^a

Birth weight (g)

2795.42 ± 491.67

2787.73 ± 468.78

2600.94 ± 531.78^a

Birth height (cm)

47.40 ± 3.36

47.16 ± 3.24

46.17 ± 3.28^a

Apgar score (1 min)

9.92 ± 0.34

9.75 ± 0.611

9.64 ± 1.51

Admitted to the NICU (n%)

24(43.6%)

27(58.7%)^a

62(67.4%)^ab

Intrauterine death (n%)

1(1.8%)

0

2(2.2%)